Sort
15,273 grants matching “antimicrobial resistance”
Rapid, Breath Volatile Metabolite-Based Diagnostic for In Vivo Identification and Antibiotic Resistance Profiling of Bacterial Pathogens in Ventilator-Associated Pneumonia
$1,495,043Sophia Koo · Brigham And Women'S Hospital · R01 · FY2018 · AI
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection
$1,494,740Tor C. Savidge · Baylor College Of Medicine · U01 · FY2017 · AI
Establishing a Gram-Negative Permeation Rule Set Leveraging a Unique Small Molecule Library
$1,494,033Steven Armen Boyd · Venatorx Pharmaceuticals, Inc. · R01 · FY2021 · AI
The Doxy-PEP Impact Study: a multi-city US longitudinal cohort to evaluate doxy-PEP field effectiveness, investigate associated antimicrobial resistance, and establish doxy-PEP to need ratios
$1,493,206Anne Frey Luetkemeyer · University Of California, San Francisco · R01 · FY2025 · AI
Vaccine and Treatment Evaluation Units
$1,492,854Nadine Georges Rouphael · Emory University · UM1 · FY2022 · AI
PItt-Ohio State-Georgetown Clinical Trials Unit
$1,491,683John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2016 · AI
PItt-Ohio State-Georgetown Clinical Trials Unit
$1,491,683John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2017 · AI
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection
$1,486,851Tor C. Savidge · Baylor College Of Medicine · U01 · FY2020 · AI
Medication Development for the Treatment of Alcohol Use Disorder
$1,486,106Susan E. Bergeson · Texas Tech University Health Scis Center · U01 · FY2021 · AA
Anthrax Immune Globulin to Prevent & Treat Anthrax: Advanced Product Development
$1,485,126Ajoy Chakrabarti · Emergent Product Development Gaithersbur · U01 · FY2007 · AI
Immunobiology of Leprosy
$1,483,670Robert L Modlin · University Of California Los Angeles · P50 · FY2012 · AR
Immunobiology of Leprosy
$1,483,670Robert L Modlin · University Of California Los Angeles · P50 · FY2014 · AR
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection
$1,482,023Tor C. Savidge · Baylor College Of Medicine · U01 · FY2019 · AI
Funtion of Uncharacterized Genes of Acinetobacter baumanii
$1,481,971Samuel I. Miller · University Of Washington · U19 · FY2015 · AI
Infection Prevention and Antimicrobial Stewardship: Minding the Gaps: The Iowa Prevention Epicenter
$1,480,929Loreen A Herwaldt · University Of Iowa · U54 · FY2023 · CK
International Research in Cambodia: Tropical Medicine and Vector Research
$1,479,224Christina Yek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Chemical-based Nitric Oxide Gas-generating Drug Device for the Treatment of Pulmonary Hypertension
$1,478,869Gary Lessing · Inovodel, Inc. · R42 · FY2024 · HL
Establishing a Gram-Negative Permeation Rule Set Leveraging a Unique Small Molecule Library
$1,477,022Steven Armen Boyd · Venatorx Pharmaceuticals, Inc. · R01 · FY2022 · AI
Mapping polymicrobial interactions that modulate antibiotic persistence
$1,476,000Wendy W.k. Mok · University Of Connecticut Sch Of Med/Dnt · DP2 · FY2021 · GM
Task A43: Establishment of a Chronic Bacterial Lung Infection Model in Ã-ENaC Mice
$1,473,238Joanne Shanklin · Univ Of North Carolina Chapel Hill · N01 · FY2022 · AI
Development of novel endolysins targeting Cutibacterium acnes to treat acne vulgaris
$1,469,201Oliver Wei Liu · Topaz Biosciences, Inc. · R44 · FY2025 · AR
Innovative technologies to transform antibiotic discovery. Project 3 Rapid Access to Antibiotic Biosynthesis Machinery Using Synthetic Biology
$1,468,395Robert Nicol · Broad Institute, Inc. · U19 · FY2021 · AI
Chemical-based Nitric Oxide Gas-generating Drug Device for the Treatment of Pulmonary Hypertension
$1,467,953Gary Lessing · Inovodel, Inc. · R42 · FY2023 · HL
Development of Novel Antimicrobial Peptide Mimics
$1,467,735Paul B Savage · Brigham Young University · U01 · FY2011 · AI
Decreasing Bioburden to Reduce Healthcare-Associated Infections and Readmissions
$1,467,519Susan S Huang · University Of California-Irvine · UH3 · FY2016 · AI